Estradiol Reduces Activity of the Blood–Brain Barrier Na–K–Cl Cotransporter and Decreases Edema Formation in Permanent Middle Cerebral Artery Occlusion
Open accessAbstract
Estrogen has been shown to protect against stroke-induced brain damage, yet the mechanism is unknown. During the early hours of stroke, cerebral edema forms as increased transport of Na and Cl from blood into brain occurs across an intact blood-brain barrier (BBB). We showed previously that a luminal BBB Na-K-Cl cotransporter is stimulated by hypoxia and arginine vasopressin (AVP), factors present during cerebral ischemia, and that inhibition of the cotransporter by intravenous bumetanide greatly reduces edema in rats subjected to permanent middle cerebral artery occlusion (MCAO). The present study was conducted to determine whether estrogen protects in stroke at least in part by reducing activity of the BBB cotransporter, thereby decreasing edema formation. Ovariectomized rats were subjected to 210 mins of permanent MCAO after 7-day or 30-min pretreatment with 17beta-estradiol and then brain swelling and 2,3,5-triphenyltetrazolium chloride staining were assessed as measures of brain edema and lesion volume, respectively. Diffusion-weighed imaging was used to monitor permanent MCAO-induced decreases in apparent diffusion coefficient (ADC) values, an index of changes in brain water distribution and mobility. Na-K-Cl cotransporter activity of cerebral microvascular endothelial cells (CMECs) was assessed as bumetanide-sensitive K influx and cotransporter abundance by Western blot analysis after estradiol treatment. Estradiol significantly decreased brain swelling and lesion volu…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The luminal Na+-K+-Cl- cotransporter (NKCC1) mediates entry of Na+, K+, and 2Cl- from blood to endothelium.
“Theluminal Na + K + Cl -(chloride) cotransporter (NKCC1) mediates entry of Na + , K + , and 2Cl -from blood-to-endothelium (181, 447).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [447]
Cites
The blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280 · see citing works
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,294 · see citing works
From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery
Banks, W. A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.21 · Cited by 1,204 · see citing works
Nanoscale drug delivery systems and the blood–brain barrier
Khalin, I., Alyautdin, R., Ismail, N. M., Haron, M. H., & Kuznetsov, D. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s52236 · Cited by 204 · see citing works
- Authors
- O'Donnell, M. E., Lam, T. I., Tran, L. Q., Foroutan, S., & Anderson, S. E.
- Affiliations
- Department of Physiology and Membrane Biology, School of Medicine, University of California, Davis, California, USA
- University of California, Davis (US)
- ORCID
- Foroutan, Shahin
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2006-10
- Volume
- 26
- Issue
- 10
- Pages
- 1234-1249
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W2051214272
- Cited by
- 107
- References
- 1
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 8 · 2020: 5 · 2019: 7 · 2018: 8 · 2017: 3 · 2016: 4 · 2015: 4 · 2014: 14 · 2013: 5 · 2012: 9
- FWCI
- 3.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Cerebral Blood Flow & Metabolism (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Funders
- National Science Foundation (8417289)
- American Heart Association
- Philip Morris International
- National Institutes of Health (1s10rr002511-01)
- National Institute of Neurological Disorders and Stroke (NS039953, R01NS039953)
- National Center for Research Resources (RR02511)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
- Keywords
- estradiol, estrogen, blood-brain barrier, Na+-K+-2Cl- cotransporter, cerebral edema, ischemic stroke, middle cerebral artery occlusion, brain microvascular endothelial cells, hypoxia, vasopressin, bumetanide, apparent diffusion coefficient, neuroprotection
- MeSH terms
- Animals, Blood-Brain Barrier, Edema, Estradiol, Organ Size, Rats, Sprague-Dawley, Infarction, Middle Cerebral Artery, Sodium-Potassium-Chloride Symporters, Endothelial Cells, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review